DK1140918T3 - Thrombininhibitorer - Google Patents
ThrombininhibitorerInfo
- Publication number
- DK1140918T3 DK1140918T3 DK99962534T DK99962534T DK1140918T3 DK 1140918 T3 DK1140918 T3 DK 1140918T3 DK 99962534 T DK99962534 T DK 99962534T DK 99962534 T DK99962534 T DK 99962534T DK 1140918 T3 DK1140918 T3 DK 1140918T3
- Authority
- DK
- Denmark
- Prior art keywords
- thrombin inhibitors
- formula
- anticoagulants
- class
- compounds
- Prior art date
Links
- 229940122388 Thrombin inhibitor Drugs 0.000 title abstract 2
- 239000003868 thrombin inhibitor Substances 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 239000003146 anticoagulant agent Substances 0.000 abstract 1
- 229940127219 anticoagulant drug Drugs 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
- C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
- C07D205/085—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a nitrogen atom directly attached in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/022—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2
- C07K5/0222—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2 with the first amino acid being heterocyclic, e.g. Pro, Trp
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06078—Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biochemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR19980060266 | 1998-12-29 | ||
| KR1019990033490A KR20000047461A (ko) | 1998-12-29 | 1999-08-14 | 트롬빈 억제제 |
| EP99962534A EP1140918B1 (en) | 1998-12-29 | 1999-12-29 | Thrombin inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1140918T3 true DK1140918T3 (da) | 2004-12-20 |
Family
ID=26634497
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK99962534T DK1140918T3 (da) | 1998-12-29 | 1999-12-29 | Thrombininhibitorer |
Country Status (22)
| Country | Link |
|---|---|
| US (2) | US6492402B1 (ru) |
| EP (1) | EP1140918B1 (ru) |
| JP (1) | JP3847092B2 (ru) |
| KR (2) | KR20000047461A (ru) |
| CN (1) | CN1149210C (ru) |
| AT (1) | ATE273305T1 (ru) |
| AU (1) | AU765417B2 (ru) |
| BR (1) | BR9916678A (ru) |
| CA (1) | CA2355281A1 (ru) |
| CZ (1) | CZ20012429A3 (ru) |
| DE (1) | DE69919397T2 (ru) |
| DK (1) | DK1140918T3 (ru) |
| ES (1) | ES2226482T3 (ru) |
| HK (1) | HK1044936A1 (ru) |
| HU (1) | HUP0104500A3 (ru) |
| IL (1) | IL143545A (ru) |
| NO (1) | NO321739B1 (ru) |
| NZ (1) | NZ513174A (ru) |
| RU (1) | RU2221808C2 (ru) |
| TR (1) | TR200101899T2 (ru) |
| WO (1) | WO2000039124A1 (ru) |
| ZA (1) | ZA200104780B (ru) |
Families Citing this family (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2000061609A2 (de) * | 1999-04-09 | 2000-10-19 | Basf Aktiengesellschaft | Prodrugs von thrombininhibitoren |
| DE19934066A1 (de) * | 1999-07-23 | 2001-01-25 | Basf Ag | Verfahren zur Herstellung von 4-Cyano-2-aminomethylthiazol |
| DE19933861A1 (de) * | 1999-07-23 | 2001-01-25 | Basf Ag | Verfahren zur Herstellung von 2-Aminomethyl-4-cyano-thiazol |
| DE10049937A1 (de) * | 2000-10-06 | 2002-04-11 | Knoll Ag | Niedermolekulare Inhibitoren von Serinproteasen mit Polyhydroxyalkyl- und Polyhydroxycycloalkylresten |
| KR100447421B1 (ko) | 2001-04-04 | 2004-09-07 | 주식회사 엘지생명과학 | 5-(아미노메틸)-2-티오펜카보니트릴 염산염의 연속반응에의한 새로운 제조방법 |
| MXPA04009101A (es) * | 2002-03-22 | 2004-12-06 | Lg Life Sciences Ltd | Sal de acido maleico de (2s) -n-{5- [amino(imino) metil]-2 -tienil} metil-1 -{(2r)- 2-[(carboximetil) amino]-3, 3- difenilpropanoil} -2-pirrolidin carboxamida y un proceso para preparacion de la misma. |
| CA2479888A1 (en) * | 2002-03-22 | 2003-10-02 | Kwan-Hyung Cho | New crystalline forms of (2s)-n-5-¬amino(imino)methyl|-2-thienylmethyl-1-(2r)-2-¬(carboxymethyl)amino|-3,3-diphenylpropanoyl-2-pyrrolidinecarboxamide nh2o |
| AU2003245060A1 (en) * | 2002-06-27 | 2004-01-19 | Lg Life Sciences Ltd. | Peptidic thrombin inhibitor compound |
| US7097967B2 (en) | 2002-10-24 | 2006-08-29 | Lg Life Sciences Ltd. | Method of predicting drug-food interaction |
| US7399870B2 (en) * | 2004-03-30 | 2008-07-15 | Wyeth | Synthesis of pyrrole-2-carbonitriles |
| GB0507577D0 (en) | 2005-04-14 | 2005-05-18 | Novartis Ag | Organic compounds |
| US7678917B2 (en) * | 2005-09-01 | 2010-03-16 | Hoffman-La Roche Inc. | Factor Xa inhibitors |
| BRPI0617165B1 (pt) | 2005-10-07 | 2023-10-03 | Exelixis Inc | Compostos inibidores mek, composições farmacêuticas que os contem e métodos de uso dos mesmos |
| CA2651762A1 (en) | 2006-05-23 | 2007-11-29 | Irm Llc | Compounds and compositions as channel activating protease inhibitors |
| US20080287687A1 (en) * | 2006-11-03 | 2008-11-20 | Ajinomoto Co. Inc | Production method of diphenylalanine-Ni (II) complex |
| MX2009008518A (es) | 2007-02-09 | 2009-08-20 | Irm Llc | Compuestos y composiciones como inhibidores de la proteasa activadora de canal. |
| WO2008135525A2 (en) * | 2007-05-02 | 2008-11-13 | Boehringer Ingelheim International Gmbh | Substituted azetidines, manufacturing and use thereof as medicaments |
| KR101955691B1 (ko) | 2010-03-30 | 2019-03-07 | 베르선 코포레이션 | 트롬빈 억제제로서의 다중치환된 방향족 화합물 |
| US9273028B2 (en) | 2010-10-29 | 2016-03-01 | Biogen Ma Inc. | Heterocyclic tyrosine kinase inhibitors |
| CN104837826B (zh) | 2012-10-12 | 2018-07-27 | 埃克塞里艾克西斯公司 | 制备用于治疗癌症的化合物的新型方法 |
| RU2019101889A (ru) | 2013-03-15 | 2019-03-28 | Версеон Корпорейшн | Полизамещенные ароматические соединения в качестве ингибиторов сериновых протеаз |
| JP6479749B2 (ja) | 2013-03-15 | 2019-03-06 | ヴァーセオン コーポレイション | トロンビン阻害剤としてのハロゲノピラゾール |
| WO2016044662A1 (en) | 2014-09-17 | 2016-03-24 | Verseon Corporation | Pyrazolyl-substituted pyridone compounds as serine protease inhibitors |
| EP3261639B1 (en) | 2015-02-27 | 2022-08-24 | Verseon International Corporation | Substituted pyrazole compounds as serine protease inhibitors |
| WO2017035405A1 (en) | 2015-08-26 | 2017-03-02 | Achillion Pharmaceuticals, Inc. | Amino compounds for treatment of immune and inflammatory disorders |
| WO2017035401A1 (en) | 2015-08-26 | 2017-03-02 | Achillion Pharmaceuticals, Inc. | Amide compounds for treatment of immune and inflammatory disorders |
| WO2018160891A1 (en) | 2017-03-01 | 2018-09-07 | Achillion Pharmaceutical, Inc. | Pharmaceutical compounds for treatment of medical disorders |
| IL294069B2 (en) | 2017-03-01 | 2023-11-01 | Achillion Pharmaceuticals Inc | Aryl, heteroaryl and heterocyclic pharmaceutical compounds for the treatment of medical disorders |
| BR112020024148A2 (pt) * | 2018-05-29 | 2021-03-30 | Omeros Corporation | Compostos, composição farmacêutica, e, métodos para identificação de uma pequena molécula capaz de inibir masp-2 e para o tratamento de uma doença ou transtorno associado a masp-2 |
| KR20210057086A (ko) | 2018-09-06 | 2021-05-20 | 아칠리온 파르마세우티칼스 인코포레이티드 | 다니코판의 형태체 형태 |
| WO2020069024A1 (en) | 2018-09-25 | 2020-04-02 | Achillion Pharmaceuticals, Inc. | Morphic forms of complement factor d inhibitors |
| WO2020198062A1 (en) * | 2019-03-22 | 2020-10-01 | Achillion Pharmaceuticals, Inc. | Pharmaceutical compounds for the treatment of complement mediated disorders |
| JP2023504543A (ja) | 2019-12-04 | 2023-02-03 | オメロス コーポレーション | Ｍａｓｐ－２阻害剤および使用方法 |
| WO2021113698A1 (en) | 2019-12-04 | 2021-06-10 | Omeros Corporation | Masp-2 inhibitors and methods of use |
| CA3159176A1 (en) | 2019-12-04 | 2021-06-10 | Neil S. Cutshall | Masp-2 inhibitors and methods of use |
| WO2023183405A2 (en) * | 2022-03-22 | 2023-09-28 | Alexion Pharmaceuticals, Inc. | Pharmaceutical compounds for the treatment of complement mediated disorders |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE9301916D0 (sv) * | 1993-06-03 | 1993-06-03 | Ab Astra | New peptides derivatives |
| US5705487A (en) * | 1994-03-04 | 1998-01-06 | Eli Lilly And Company | Antithrombotic agents |
| US5726159A (en) * | 1994-03-04 | 1998-03-10 | Eli Lilly And Company | Antithrombotic agents |
| ZA951617B (en) * | 1994-03-04 | 1997-02-27 | Lilly Co Eli | Antithrombotic agents. |
| US5707966A (en) * | 1994-03-04 | 1998-01-13 | Eli Lilly And Company | Antithrombotic agents |
| EA002767B1 (ru) | 1995-02-10 | 2002-08-29 | Басф Акциенгезельшафт | Ингибиторы тромбина |
| US5914319A (en) | 1995-02-27 | 1999-06-22 | Eli Lilly And Company | Antithrombotic agents |
| US5710130A (en) * | 1995-02-27 | 1998-01-20 | Eli Lilly And Company | Antithrombotic agents |
| IL123986A (en) * | 1997-04-24 | 2011-10-31 | Organon Nv | Medicinal compounds |
| CA2317761A1 (en) * | 1998-01-26 | 1999-07-29 | Basf Aktiengesellschaft | Thrombin inhibitors |
| JP2002501044A (ja) * | 1998-01-26 | 2002-01-15 | ビーエーエスエフ アクチェンゲゼルシャフト | カリクレインプロテアーゼ阻害剤としての複素環アミジン |
-
1999
- 1999-08-14 KR KR1019990033490A patent/KR20000047461A/ko active Search and Examination
- 1999-12-29 IL IL14354599A patent/IL143545A/xx not_active IP Right Cessation
- 1999-12-29 CN CNB998151815A patent/CN1149210C/zh not_active Expired - Fee Related
- 1999-12-29 NZ NZ513174A patent/NZ513174A/en unknown
- 1999-12-29 ES ES99962534T patent/ES2226482T3/es not_active Expired - Lifetime
- 1999-12-29 DK DK99962534T patent/DK1140918T3/da active
- 1999-12-29 BR BR9916678-0A patent/BR9916678A/pt not_active IP Right Cessation
- 1999-12-29 CZ CZ20012429A patent/CZ20012429A3/cs unknown
- 1999-12-29 RU RU2001121138/04A patent/RU2221808C2/ru not_active IP Right Cessation
- 1999-12-29 TR TR2001/01899T patent/TR200101899T2/xx unknown
- 1999-12-29 CA CA002355281A patent/CA2355281A1/en not_active Abandoned
- 1999-12-29 DE DE69919397T patent/DE69919397T2/de not_active Expired - Fee Related
- 1999-12-29 JP JP2000591035A patent/JP3847092B2/ja not_active Expired - Fee Related
- 1999-12-29 US US09/473,681 patent/US6492402B1/en not_active Expired - Fee Related
- 1999-12-29 KR KR10-2001-7008401A patent/KR100462974B1/ko not_active IP Right Cessation
- 1999-12-29 AT AT99962534T patent/ATE273305T1/de not_active IP Right Cessation
- 1999-12-29 HU HU0104500A patent/HUP0104500A3/hu unknown
- 1999-12-29 AU AU18951/00A patent/AU765417B2/en not_active Ceased
- 1999-12-29 WO PCT/KR1999/000830 patent/WO2000039124A1/en not_active Application Discontinuation
- 1999-12-29 EP EP99962534A patent/EP1140918B1/en not_active Expired - Lifetime
-
2001
- 2001-06-12 ZA ZA200104780A patent/ZA200104780B/en unknown
- 2001-06-27 NO NO20013220A patent/NO321739B1/no unknown
-
2002
- 2002-07-22 HK HK02105401.0A patent/HK1044936A1/zh unknown
- 2002-11-01 US US10/285,417 patent/US6864249B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1140918T3 (da) | Thrombininhibitorer | |
| ATE297203T1 (de) | Antithrombotische mitteln | |
| CY1107634T1 (el) | Φαρμακευτικη συνθεση | |
| ATE306261T1 (de) | Antithrombosemittel | |
| EA199900937A1 (ru) | Фармацевтические композиции, содержащие вориконазол | |
| BR0108893B1 (pt) | composiÇço farmacÊutica contendo derivados de azetidina, composto derivado de azetidina, e, processo para a preparaÇço de compostos. | |
| DE602004008098D1 (de) | Substituierte 2h-ä1,2,4ütriazoloä4,3-aüpyrazine als gsk-3-inhibitoren | |
| ATE272633T1 (de) | Aromatische amiden | |
| NO20003018D0 (no) | Triazinangiogenese-inhibitorer | |
| DK0705254T3 (da) | Phenylheterocykliske forbindelser som cyclooxygenase-2-inhibitorer | |
| SE9203825D0 (sv) | Dual inhibitors of no synthase and cyclooxygenase, process for their preparation and therapeutical compositions containing them | |
| EE200200045A (et) | Asendatud oksoasaheterotsüklüülühendid, farmatseutiline kompositsioon ja vaheühendid | |
| TR200002182T2 (tr) | İkame edilmiş aksozaherosayklil faktör xa inhibitörleri | |
| PL361404A1 (en) | Synergistic combinations comprising a renin inhibitor for cardiovascular diseases | |
| DE69931393D1 (de) | Antithrombotische amide | |
| NO991494D0 (no) | <beta>-sulfonylhydroksaminsyrer som matriksmetalloproteinaseinhibitorer | |
| EA200500312A1 (ru) | Новые спироконденсированные хиназолиноны и их применение в качестве ингибиторов фосфодиэстераз | |
| DK0715623T3 (da) | Blodpladeaggregationsinhibitorer | |
| UY26780A1 (es) | Cicloalquil avb3 antagonistas | |
| CO5261493A1 (es) | Procedimiento y compuestos para la inhibicion de la mrp1 | |
| DE60330758D1 (de) | Bestimmte pharmazeutisch wertvolle substituierte aminoalkyl-heterocyclen | |
| DK0804418T3 (da) | Platelataggregationshæmmere | |
| ATE308540T1 (de) | Antithrombosemittel | |
| ATE253359T1 (de) | Antithrombotische mittel | |
| ATE382607T1 (de) | Antitrombotische aether |